company background image
509079 logo

Gufic Biosciences BSE:509079 Stock Report

Last Price

₹283.15

Market Cap

₹28.4b

7D

-4.0%

1Y

49.9%

Updated

28 Mar, 2024

Data

Company Financials

Gufic Biosciences Limited

BSE:509079 Stock Report

Market Cap: ₹28.4b

509079 Stock Overview

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally.

509079 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance3/6
Financial Health4/6
Dividends0/6

Gufic Biosciences Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Gufic Biosciences
Historical stock prices
Current Share Price₹283.15
52 Week High₹364.00
52 Week Low₹181.60
Beta0.82
1 Month Change-10.27%
3 Month Change-10.25%
1 Year Change49.89%
3 Year Change143.88%
5 Year Change278.54%
Change since IPO1,652.17%

Recent News & Updates

Recent updates

Shareholder Returns

509079IN PharmaceuticalsIN Market
7D-4.0%2.7%2.5%
1Y49.9%63.9%47.3%

Return vs Industry: 509079 underperformed the Indian Pharmaceuticals industry which returned 63.9% over the past year.

Return vs Market: 509079 exceeded the Indian Market which returned 47.3% over the past year.

Price Volatility

Is 509079's price volatile compared to industry and market?
509079 volatility
509079 Average Weekly Movement4.6%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.6%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 509079's share price has been volatile over the past 3 months.

Volatility Over Time: 509079's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19701,628Pranav Choksihttps://www.gufic.com

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally. The company manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. It manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments.

Gufic Biosciences Limited Fundamentals Summary

How do Gufic Biosciences's earnings and revenue compare to its market cap?
509079 fundamental statistics
Market cap₹28.39b
Earnings (TTM)₹841.95m
Revenue (TTM)₹7.85b

33.7x

P/E Ratio

3.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
509079 income statement (TTM)
Revenue₹7.85b
Cost of Revenue₹3.91b
Gross Profit₹3.93b
Other Expenses₹3.09b
Earnings₹841.95m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 30, 2024

Earnings per share (EPS)8.40
Gross Margin50.13%
Net Profit Margin10.73%
Debt/Equity Ratio91.8%

How did 509079 perform over the long term?

See historical performance and comparison

Dividends

0.04%

Current Dividend Yield

1%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.